Morning Market Gainers

shares surged 27.36 percent to $4.05 after the company reported that it has received a Special Protocol Assessment and commenced second Phase III pivotal trial of Ampion.

shares jumped 22.72 percent to $9.94 after climbing 18.25 percent yesterday. On Monday, Chardan Capital initiated coverage on Vascular Biogenics with a Buy rating and a $25.00 price target.

shares rose 13.15 percent to $4.13. On Monday, Can-Fite BioPharma reported a $9 million registered direct offering at $4.35 per share.

shares surged 9.04 percent to $3.02 after the company reported that it has received a U.S. Patent for the treatment of prostate cancer.

shares rose 9.10 percent to $9.18 after the company announced that it won't pursue concurrent public offerings of ordinary shares and mandatory exchangeable subordinated notes.

shares gained 8.76 percent to $4.72. H.C. Wainwright initiated coverage on Conatus Pharmaceuticals with a Buy rating and a $15.00 price target.